AlloSource collaborated with NASA and JPL scientists on a study to characterize the effects of zero gravity on antibiotic resistant genes in microorganisms taken from the International Space Station (ISS). In this role, AlloSource assisted in describing antimicrobial capabilities of microbes isolated from the ISS.
The study, titled Targeted Amplification of Antibiotic Resistant Genes Associated with the International Space Station Environment, investigates the impact of zero gravity on microbes by looking at the change in resistance over time compared to similar strains on earth. The ongoing project will help NASA and JPL scientists and medical staff to more efficiently prescribe antibiotics on the ISS.
In addition to participating in the study, AlloSource continues to leverage technologies developed by NASA and JPL for assembly and launch operations of various Mars missions – specifically, rapid molecular microbial burden measurement and genetic inventory cataloging – to advance microbial research in tissue processing.
“This work with NASA and JPL on microbial research efforts aligns with our commitment to improve processes at AlloSource in order to fully maximize the gift of tissue donation,” said Dr. Peter Stevens, PhD, AlloSource Vice President of Development and Growth.
AlloSource will use the research on microbiological testing methods to look for new ways to rapidly detect the presence of microorganisms to benefit allograft availability for patients.
Denver Broncos running backs coach Eric Studesville recently shared his personal connection to donation and how it has impacted his life. While enduring a devastating personal loss, Studesville has found hope and solace in working with Donor Alliance to promote organ, eye and tissue donation.
Read more about this story here.
On any given day, Meg would be out the door before the sun rose, ready to coach for USA Cycling or teach a yoga class. As an endurance athlete and mother to a busy toddler, her health is crucial to her lifestyle.
Though she endured knee pain for several years, a fall off of her mountain bike was the catalyst to a visit with an orthopedic surgeon.
“After my knee scope, it was clear there was a bigger issue,” Meg said. “I basically had no cartilage left on my knee.”
AlloSource’s ProChondrix is a fresh osteochondral allograft that helps deliver the necessary components for cartilage restoration. This next generation of cartilage therapy provides live cells and other biological components, which are necessary for repair and regeneration of damaged cartilage tissues.
Dr. Mehta felt ProChondrix would help give Meg back her quality of life. Before embarking down a surgical path, Meg and Dr. Mehta had several in-depth conversations about the procedure and ProChondrix.
“Dr. Mehta asked me, ‘where do you want to be in a year? Do you want to still be in pain when you go out for a run or a ride? Or do you want to feel pain-free and feel like you have control of your knee?’” she explained.
Meg felt confident in ProChondrix and Dr. Mehta and underwent surgery in the summer of 2015. After the procedure, Meg began an aggressive physical therapy regimen and is now back on her bike both coaching and riding for fun.
She recently visited AlloSource and got to see firsthand how allografts are processed. She also reflected on what it means to receive donated human tissue.
When she talks about her experience, Meg’s feelings of gratitude and excitement are tangible.
“Hands down, this was the best decision for me,” she said. “My deep knee pain is gone, I’m functional and I can keep up with my son again. It’s a world of difference.”
The Association for Multicultural Affairs in Transplantation (AMAT) and Donate Life America (DLA) joined forces in 2015 to develop Donate Life ECHO, which stands for Every Community Has Opportunity. It is celebrated July 10 – 23, 2016, as a nationwide observance designed to reach multicultural communities.
The observance has two objectives: one is to focus on the power of sharing one’s personal decision to register as an organ, eye and tissue donor with members of one’s community; the second is to encourage registered donors to ask members of their personal networks and extended communities to talk about organ, eye and tissue donation and register as donors.
Learn more here.
Through a simple sign up process, iPhone users can learn more and take action with just a few taps. All registrations submitted from iPhone are sent directly to the National Donate Life Registry managed by Donate Life America. The ability to quickly and easily become a nationally-registered donor enables people to carry their decision with them wherever they go.
Read more about this exciting partnership here.